Announced details
In pharmaceutical and drug-manufacturing laboratories, pretreatment for HPLC and colorimetric analysis is said to account for 60% of the actual work. Other quantified implementation benefits are Not disclosed.
株式会社ASCe is a group company of the Company. The capital, personnel and business relationships with 株式会社兼松KGK are Not disclosed.
A company that sells machine tools, industrial machinery, energy-related equipment and related products, and organizes exhibitions. Other company information is Not disclosed.
Yamagata International Exchange Plaza “Yamagata Big Wing,” Assembly and Exhibition Halls 1 and 2, 100 Hirakubo, Yamagata City, Yamagata Prefecture
The Company states that it will promote improved profitability and expansion of its business domains, as set out in its medium-term management plan, “Value Creation 28.” The specific impact on results is Not disclosed.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Automated dispensing system, P-Bas®（Punch Bonding and sintering）, Precision metal processing components |
| Counterparty | 株式会社兼松KGK |
| Counterparty overview | A company that sells machine tools, industrial machinery, energy-related equipment and related products, and organizes exhibitions. Other company information is Not disclosed. |
| Relationship with the Company | 株式会社ASCe is a group company of the Company. The capital, personnel and business relationships with 株式会社兼松KGK are Not disclosed. |
| Launch date | 3 June 2026 (scheduled; the exhibition date) |
| Applicable area | Healthcare, Scientific research, Pharmaceuticals, Healthcare, Molds for plastic injection molding, Harsh environments such as outer space |
| Location | Yamagata International Exchange Plaza “Yamagata Big Wing,” Assembly and Exhibition Halls 1 and 2, 100 Hirakubo, Yamagata City, Yamagata Prefecture |
| Quantitative Effects | In pharmaceutical and drug-manufacturing laboratories, pretreatment for HPLC and colorimetric analysis is said to account for 60% of the actual work. Other quantified implementation benefits are Not disclosed. |
| Impact on Business Performance | The Company states that it will promote improved profitability and expansion of its business domains, as set out in its medium-term management plan, “Value Creation 28.” The specific impact on results is Not disclosed. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The exhibition is intended to raise awareness of automation solutions and P-Bas®, develop new customers, and deepen relationships with existing customers.